Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020. 2023

Grace R Macklin, and Ajay K Goel, and Ondrej Mach, and Graham Tallis, and Jamal A Ahmed, and Kathleen M O'Reilly, and Nicholas C Grassly, and Ousmane M Diop
Polio Eradication, World Health Organisation, Geneva, Switzerland; London School of Hygiene and Tropical Medicine, London, UK. Electronic address: mackling@who.int.

The number and geographic breadth of circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks detected after the withdrawal of type 2 containing oral polio vaccine (April 2016) have exceeded forecasts.Using Acute Flaccid Paralysis (AFP) investigations and environmental surveillance (ES) data from the Global Polio Laboratory Network, we summarize the epidemiology of cVDPV2 outbreaks. Between 01 January 2016 to 31 December 2020, a total of 68 unique cVDPV2 genetic emergences were detected across 34 countries. The cVDPV2 outbreaks have been associated with 1596 acute flaccid paralysis cases across four World Health Organization regions: 962/1596 (60.3%) cases occurred in African Region; 619/1596 (38.8%) in the Eastern Mediterranean Region; 14/1596 (0.9%) in Western-Pacific Region; and 1/1596 (0.1%) in the European Region. As the majority of the cVDPV2 outbreaks have been seeded through monovalent type 2 oral poliovirus vaccine (mOPV2) use in outbreak responses, the introduction of the more stable novel oral poliovirus vaccine will be instrumental in stopping emergence of new cVDPV2 lineages.

UI MeSH Term Description Entries
D011051 Poliomyelitis An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5) Infantile Paralysis,Polio,Poliomyelitis, Nonpoliovirus,Poliomyelitis, Preparalytic,Encephalitis, Polio,Epidemic Acute Poliomyelitis,Polio Encephalitis,Poliomyelitis Infection,Poliomyelitis, Acute,Acute Poliomyelitis,Acute Poliomyelitis, Epidemic,Infection, Poliomyelitis,Infections, Poliomyelitis,Nonpoliovirus Poliomyelitis,Paralysis, Infantile,Poliomyelitides, Preparalytic,Poliomyelitis Infections,Poliomyelitis, Epidemic Acute,Polios,Preparalytic Poliomyelitis
D011055 Poliovirus Vaccine, Oral A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed) Sabin Vaccine,Oral Poliovirus Vaccine,Vaccine, Oral Poliovirus,Vaccine, Sabin
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014943 Global Health A multi- and interdisciplinary field concerned with improving health and achieving equity in health for all people. It transcends national boundaries, promotes cooperation and collaboration within and beyond health science fields, and combines population-based disease prevention with individually-based patient care. International Health Problems,World Health,International Health,Worldwide Health,Health Problem, International,Health Problems, International,Health, Global,Health, International,Health, World,Health, Worldwide,Healths, International,International Health Problem,International Healths,Problem, International Health,Problems, International Health
D017955 Poliovirus A species of ENTEROVIRUS which is the causal agent of POLIOMYELITIS in humans. Three serotypes (strains) exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector (flies). Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection. Brunhilde Virus,Human poliovirus 1,Human poliovirus 2,Human poliovirus 3,Lansing Virus,Leon Virus,Poliovirus Type 1,Poliovirus Type 2,Poliovirus Type 3,Polioviruses

Related Publications

Grace R Macklin, and Ajay K Goel, and Ondrej Mach, and Graham Tallis, and Jamal A Ahmed, and Kathleen M O'Reilly, and Nicholas C Grassly, and Ousmane M Diop
April 2023, Vaccine,
Grace R Macklin, and Ajay K Goel, and Ondrej Mach, and Graham Tallis, and Jamal A Ahmed, and Kathleen M O'Reilly, and Nicholas C Grassly, and Ousmane M Diop
April 2020, MMWR. Morbidity and mortality weekly report,
Grace R Macklin, and Ajay K Goel, and Ondrej Mach, and Graham Tallis, and Jamal A Ahmed, and Kathleen M O'Reilly, and Nicholas C Grassly, and Ousmane M Diop
December 2021, MMWR. Morbidity and mortality weekly report,
Grace R Macklin, and Ajay K Goel, and Ondrej Mach, and Graham Tallis, and Jamal A Ahmed, and Kathleen M O'Reilly, and Nicholas C Grassly, and Ousmane M Diop
April 2023, Vaccine,
Grace R Macklin, and Ajay K Goel, and Ondrej Mach, and Graham Tallis, and Jamal A Ahmed, and Kathleen M O'Reilly, and Nicholas C Grassly, and Ousmane M Diop
May 2017, MMWR. Morbidity and mortality weekly report,
Grace R Macklin, and Ajay K Goel, and Ondrej Mach, and Graham Tallis, and Jamal A Ahmed, and Kathleen M O'Reilly, and Nicholas C Grassly, and Ousmane M Diop
April 2023, Vaccine,
Grace R Macklin, and Ajay K Goel, and Ondrej Mach, and Graham Tallis, and Jamal A Ahmed, and Kathleen M O'Reilly, and Nicholas C Grassly, and Ousmane M Diop
October 2022, Emerging infectious diseases,
Grace R Macklin, and Ajay K Goel, and Ondrej Mach, and Graham Tallis, and Jamal A Ahmed, and Kathleen M O'Reilly, and Nicholas C Grassly, and Ousmane M Diop
April 2023, Vaccine,
Grace R Macklin, and Ajay K Goel, and Ondrej Mach, and Graham Tallis, and Jamal A Ahmed, and Kathleen M O'Reilly, and Nicholas C Grassly, and Ousmane M Diop
June 2024, Vaccine: X,
Grace R Macklin, and Ajay K Goel, and Ondrej Mach, and Graham Tallis, and Jamal A Ahmed, and Kathleen M O'Reilly, and Nicholas C Grassly, and Ousmane M Diop
January 2001, Releve epidemiologique hebdomadaire,
Copied contents to your clipboard!